Please assess the completion status of the following clinical trial:

Trial Title: Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Completed Day 28 of either the DRM04-HH04 or DRM04-HH05 study with at least 80% treatment compliance~* Male or females~Exclusion Criteria:~* Subject has a clinically significant abnormality on physical exam, vital signs or ECG at the Week 4 visit of DRM04-HH04 or DRM04-HH05 study that would make further treatment with glycopyrronium contraindicated~* Male with a history of urinary retention requiring catheterization due to prostatic hypertrophy or severe obstructive symptoms of prostatic hypertrophy~* Any other condition which, in the judgement of the Investigator, would put the subject at unacceptable risk for participation in the study

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Glycopyrronium (Type: EXPERIMENTAL): Glycopyrronium Topical Wipes

Based on this trial design, predict the completion outcome and termination type (if applicable).